Mechanistically, we found that mAb-2E3 was able to bind the active form of PAI-1, inhibit metastasis of esophageal cancer in an LRP1-dependent manner, and block the binding between LRP1-Cluster II and PAI-1. Here, LRP1 is linked to esophageal cancer.